These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24236617)

  • 21. Evidence for short-term psychodynamic psychotherapy for depression.
    Abbass AA; Shedler J; Town JM
    J Clin Psychiatry; 2012 May; 73(5):718; author reply 718-20. PubMed ID: 22697196
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manic psychosis after sertraline and transcranial direct-current stimulation.
    Brunoni AR; Valiengo L; Zanao T; de Oliveira JF; Bensenor IM; Fregni F
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):E4-5. PubMed ID: 21948925
    [No Abstract]   [Full Text] [Related]  

  • 24. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome.
    Isserles M; Rosenberg O; Dannon P; Levkovitz Y; Kotler M; Deutsch F; Lerer B; Zangen A
    J Affect Disord; 2011 Feb; 128(3):235-42. PubMed ID: 20663568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressants plus exercise an antidote to depression.
    Duke Med Health News; 2006 Nov; 12(11):4. PubMed ID: 17228394
    [No Abstract]   [Full Text] [Related]  

  • 26. Vagus nerve stimulation for depression: efficacy and safety in a European study.
    Schlaepfer TE; Frick C; Zobel A; Maier W; Heuser I; Bajbouj M; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; Van den Abbeele D; Stanga Z; Hasdemir M
    Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Authors' reply.
    Moradveisi L; Huibers MJ; Renner F; Arasteh M; Arntz A
    Br J Psychiatry; 2013 Jun; 202():466-7. PubMed ID: 24734270
    [No Abstract]   [Full Text] [Related]  

  • 29. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of adolescent depression: 6 months after treatment.
    Gordon MS; Tonge B; Melvin GA
    Aust N Z J Psychiatry; 2011 Mar; 45(3):232-9. PubMed ID: 21128873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise as an effective treatment option for major depression in older adults.
    Miser WF
    J Fam Pract; 2000 Feb; 49(2):109-10. PubMed ID: 10718684
    [No Abstract]   [Full Text] [Related]  

  • 33. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical exercise for late-life depression: Effects on symptom dimensions and time course.
    Murri MB; Ekkekakis P; Menchetti M; Neviani F; Trevisani F; Tedeschi S; Latessa PM; Nerozzi E; Ermini G; Zocchi D; Squatrito S; Toni G; Cabassi A; Neri M; Zanetidou S; Amore M
    J Affect Disord; 2018 Apr; 230():65-70. PubMed ID: 29407540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women.
    Schneider LS; Small GW; Clary CM
    Am J Geriatr Psychiatry; 2001; 9(4):393-9. PubMed ID: 11739065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results for behavioural activation are overstated.
    Kripalani M; Suleman M
    Br J Psychiatry; 2013 Jun; 202():466. PubMed ID: 23732939
    [No Abstract]   [Full Text] [Related]  

  • 38. Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Jain S
    J Am Psychoanal Assoc; 2014 Feb; 62(1):113-5. PubMed ID: 24610762
    [No Abstract]   [Full Text] [Related]  

  • 39. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression].
    Szádóczky E; Füredi J
    Encephale; 2002; 28(4):343-9. PubMed ID: 12232543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.